• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Recipharm and Exela announce exclusive strategic alliance

    PRESS RELEASE

    Enforcement Report - Week of November 29, 2023

    FDA

    Exela Pharma`s Generic Acetylcysteine Receives Approval in the U.S.

    FDA

    Exela recalls 3 separate drugs over particulate concerns

    FIERCE PHARMA

    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL, and ELCYS (cysteine hydrochloride Injection), USP 500 mg/10 mL Due to the Presence of Particulate Matter

    FDA

    Enforcement Report - Week of December 21, 2022

    FDA

    Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection

    FDA

    Enforcement Report - Week of November 2, 2022

    FDA

    Exela`s Generic Cupric Chloride Receives Approval in the U.S.

    FDA

    Flying glass fears force Exela to recall 49 lots of metabolic acidosis injection

    FIERCEPHARMA

    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection

    FDA

    Fish & Richardson Secures Win for Exela Pharma Sciences

    BUSINESSWIRE

    Enforcement Report - Week of January 19, 2022

    FDA

    Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences

    BUSINESSWIRE

    Exela Pharma`s Zinc chloride Receives Approval in US

    FDA

    Exela Pharma`s Acetylcysteine Receives Approval in US

    FDA

    Enforcement Report - Week of September 23, 2020

    FDA

    Exela Pharma`s Generic Erythromycin Lactobionate Receives Approval In US

    FDA

    Exela Pharma`s Acyclovir Sodium Receives Approval in US

    FDA

    Latest Civica Rx pact aims to alleviate shortage of emergency medicine

    HEALTHCAREDIVE

    Exela Pharma`s Generic Folic Acid Receives Approval in US

    FDA

    Civica signs supply agreement for medicine, after hospitals ration use

    IN-PHARMATECHNOLOGIST

    Civica Rx and Exela Pharma Sciences Join Forces

    PRESS RELEASE

    Enforcement Report - Week of May 30, 2018

    FDA

    Exela Issues Voluntary Recall of Ibuprofen Lysine Injection

    FDA

    EXELA PHARMA SCS LLC Palonosetron Hydrochloride Approved By FDA

    FDA

    Exela Pharma’s Generic Ibuprofen Lysine approved in US a NSAID

    FDA

    Exela Pharma Sciences LLC v. Lee

    PATENT DOCS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.